Industry experts have raised alarm that lack of financial assistance and guidance on technical expertise have marred pharma MSMEs’ prospects to comply with revised Schedule M guidelines of December 31 ...
With nearly 75% of the pharma units yet to begin upgradation work for their manufacturing facilities, the government might be forced to extend the deadline to implement revised Schedule M guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback